Zeffix

Generic name/Active ingredient: Lamivudine 100 mg

Trade name: Zeffix

Dosage form: Tablet

Drug classification: Nucleoside and nucleotide reverse transcriptase inhibitors antivirals

Legal classification: POM

Company: GlaxoSmithKline

Commonly used for: Treatment of patients ≥16 yr w/ chronic hepatitis B & evidence of HBV replication w/ ≥1 of the following conditions: Elevated serum ALT ≥2x normal, liver cirrhosis, decompensated liver disease, biopsy-proven necro-inflammatory liver disease, immunocompromised state, liver transplant.